Genentech is reducing the concentration of Tamiflu [oseltamivir] oral suspension from 12 mg/mL to 6 mg/mL,
- PDF / 136,184 Bytes
- 1 Pages / 595.245 x 841.846 pts (A4) Page_size
- 121 Downloads / 196 Views
1
■ Genentech is reducing the concentration of Tamiflu [oseltamivir] oral suspension from 12 mg/mL to 6 mg/mL, as this lower concentration is less likely to become frothy when shaken, which helps ensure an accurate measurement and reduces the possibility of dosing errors. The US FDA is highlighting that there are no quality issues with the 12 mg/mL product; however, it is encouraging wholesale buyers, distributors and pharmacies to participate in the manufacturer’s Take Back Program, to limit the potential for confusion resulting from having both concentrations available on the market. FDA. FDA Drug Safety Communication: Important safety changes to the influenza drug Tamiflu (oseltamivir phosphate) for oral suspension. Internet Document : [3 pages], 12 Jul 2011. Available from: URL: http:// 803057458 www.fda.gov
0114-9954/10/1360-0001/$14.95 © 2010 Adis Data Information BV. All rights reserved
Reactions 16 Jul 2011 No. 1360
Data Loading...
